bupropion semaglutide Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health Successful naltrexone-bupropion treatment after several

Health Canada is warning the public of seized unauthorized injectable peptide drugs from Canada Peptide

Cardiovascular disease (CVD) is the main cause of death and disability among people with type 2 diabetes.[2] Adults with type 2 diabetes are two to four times more likely to develop CVD than adults without diabetes.[3] The FDA's decision on semaglutide is based on results from the SUSTAIN 6 cardiovascular outcomes trial (CVOT), which examined the cardiovascular safety of adding Ozempic or placebo to standard-of-care in adults with type 2 diabetes and established cardiovascular disease

This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists.GLP-1 Agonists What is it?

A new weight loss center has opened in Baton Rouge, offering patients access to GLP-1 medications and personalized lifestyle guidance.

Low Impact